<DOC>
	<DOCNO>NCT00868959</DOCNO>
	<brief_summary>This clinical study design test hypothesis lurasidone effective , tolerable , safe treatment patient bipolar I depression</brief_summary>
	<brief_title>Lurasidone - A 24-week Extension Study Patients With Bipolar I Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>Subject judge investigator suitable participation 24week clinical trial involve openlabel lurasidone treatment Subject complete 6week treatment period require assessment final study visit ( Day 42 , Visit 8 ) either Study D1050235 , NCT # 00868452 Study D1050236 , NCT # 008668699 . Imminent risk suicide , injury self others , damage property Subject evidence severe movement disorder . Subject test positive drug abuse ( Visit 8 Study D1050235 , NCT # 00868452 D1050236 , NCT # 008688699 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Bipolar</keyword>
	<keyword>Depression</keyword>
	<keyword>Lurasidone</keyword>
	<keyword>Latuda</keyword>
</DOC>